Finland· FI-REL-REL11381

Otomax vet.

A beetametasoni ja mikrobilääkkeet product containing gentamicin sulfate + betamethasone valerate + clotrimazole, registered in Finland by Intervet International B.V.. The same ATC class is registered in 2 of our 19 countries.

ATC QS02CA90

Checked against Fimea (Finland) on

Informational only — not a medical device.

SOURCE REGISTER · FIFimea (Finland)normalisedOtomax vet.ATCQS02CA90REGISTER NO.FI-REL-REL11381PACKS LISTED0CHECKEDSeptember 27, 2026

Where it is registered

Gentamicin sulfate + betamethasone valerate + clotrimazole is registered in 2 of 19 countries.

Countries holding a registration under ATC QS02CA90 (beetametasoni ja mikrobilääkkeet), each read from that country’s own register.

  • This record: Finland, from Fimea (Finland)
  • 1 of them publish a price we can compare per daily dose

Gentamicin sulfate + betamethasone valerate + clotrimazole · ATC QS02CA90

2 / 19 countries

  • Denmark
  • Finlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Fimea (Finland)
Active substance
Gentamicin sulfate + Betamethasone valerate + Clotrimazole
Manufacturer
Intervet International B.V.
Country
Finland (FI)
ATC code
QS02CA90
ATC class
Beetametasoni ja mikrobilääkkeet
Reimbursed
Not published by this register
Source register
Fimea (Finland)
Last checked
September 27, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same class

Other records under QS02CA90

Beetametasoni ja mikrobilääkkeet, as other registers publish it.

All gentamicin sulfate + betamethasone valerate + clotrimazole products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • Bulgaria · Бетаклоген, Тридерм
  • Poland · Triderm
  • Romania · Tresyl, Triderm

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/20d4c995-1119-4cf8-8e22-fa1ee74c554f
GET /v1/drugs/20d4c995-1119-4cf8-8e22-fa1ee74c554f?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "ddd": null,
  "form": "korvatipat, suspensio",
  "route": "Korvaan",
  "ddd_unit": null,
  "strength": null,
  "atc_label": "Beetametasoni ja mikrobilääkkeet",
  "ma_number": "14177",
  "auth_status": "Myyntilupa myönnetty",
  "eu_ma_number": null,
  "fimea_rel_id": "REL11381",
  "authorised_at": "1999-09-23"
}

See everything about gentamicin sulfate + betamethasone valerate + clotrimazole.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.